Fort Baker Capital Management’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Fort Baker Capital Management’s Portfolio RCKTW Stock Details RCKTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-328,698	Closed	-$23.7K	–	80
2024 Q3	$23.7K	Hold	328,698	–	–	﹤0.01%	69
2024 Q2	$20K	Hold	328,698	–	–	﹤0.01%	70
2024 Q1	$98.3K	Hold	328,698	–	–	0.01%	60
2023 Q4	$161K	Sell	328,698 -48,741	-13%	-$13.5K	0.02%	61
2023 Q3	$64.2K	Hold	377,439	–	–	0.01%	68
2023 Q2	$71.7K	Hold	377,439	–	–	0.01%	68
2023 Q1	$49.4K	Buy	+377,439	New	+$72.8K	0.01%	64

Other funds holding RCKTW

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return

Walleye Capital

Walleye Capital New York $16.3B AUM 37.67% 1-Year Est. Return

Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return

Walleye Trading

Walleye Trading New York $4.86B AUM 42.19% 1-Year Est. Return

LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return

Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.69B AUM 19.05% 1-Year Est. Return